Akriti Kharbanda, PhD

Akriti Kharbanda, PhD has a diverse work experience in the field of biotechnology and medical research. Akriti is currently employed at Vor Biopharma as a Scientist II, starting in February 2022. Prior to that, they worked as a Scientist I at the same company from February 2021 to February 2022.

Before joining Vor Biopharma, Akriti worked at PRECISIONscientia as a Senior Medical Writer from August 2020 to February 2021. Earlier, they served as a Medical Writer at the same company from June 2019 to August 2020. PRECISIONscientia was previously known as ETHOS Health Communications, which was acquired by Precision Medicine Group Inc. in 2018.

Akriti's academic journey includes working as a PhD Candidate at the University of Pennsylvania from August 2014 to May 2019. Their research during this time focused on studying the role of palmitoylation in regulating receptor signaling in Kras mutant non-small cell lung cancer progression. Akriti successfully defended their dissertation on March 22, 2019.

Additionally, Akriti worked as a Pre Doctoral Fellow at the Dana-Farber Cancer Institute from June 2011 to August 2014. Prior to that, they gained experience as a Research Associate at Genus Oncology LLC from February 2010 to June 2011. Their work at Genus Oncology involved conducting in-vitro experiments for the development and characterization of an antibody against a specific protein used as a biomarker. Akriti was also involved in the development of a novel targeted breast cancer therapy.

Earlier in their career, Akriti held positions as an Organic Chemistry Preparatory Leader at the Boston University Educational Resource Center from February 2009 to February 2011. Akriti also worked as a Clinical Research Assistant Intern at Beth Israel Deaconess Medical Center from May 2009 to August 2009, where they assisted the Bone Marrow Transplant team in patient data management and other clinical processes. Lastly, they worked as a Clinical Research Assistant Intern at the Dana-Farber Cancer Institute from June 2008 to August 2008.

Overall, Akriti Kharbanda, PhD has a strong background in scientific research and medical communication, with experience in both academic and industry settings.

Dr. Akriti Kharbanda completed their education with a focus on cellular and molecular biology, specifically in the field of cancer biology. Akriti obtained their Bachelor of Arts degree in Biochemistry and Molecular Biology from Boston University in 2011. Following this, they pursued their Doctor of Philosophy (Ph.D.) degree at the University of Pennsylvania from 2014 to 2019. Prior to their college education, they attended Montrose School from 2003 to 2007. Additionally, Dr. Kharbanda obtained a certification in "From the Laboratory to Leadership" from The Leadership Edge in January 2022.